|
1
|
Herszényi L and Tulassay Z: Epidemiology
of gastrointestinal and liver tumors. Eur Rev Med Pharmacol Sci.
14:249–258. 2010.PubMed/NCBI
|
|
2
|
El-Serag HB: Epidemiology of viral
hepatitis and hepatocellular carcinoma. Gastroenterology.
142:1264–1273. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Michielsen P and Ho E: Viral hepatitis B
and hepatocellular carcinoma. Acta Gastroenterol Belg. 74:4–8.
2011.PubMed/NCBI
|
|
4
|
Li G, Cai G, Li D and Yin W: MicroRNAs and
liver disease: Viral hepatitis, liver fibrosis and hepatocellular
carcinoma. Postgrad Med J. 90:106–112. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zamore PD and Haley B: Ribo-gnome: The big
world of small RNAs. Science. 309:1519–1524. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Masaki T: MicroRNA and hepatocellular
carcinoma. Hepatol Res. 39:751–752. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Aravalli RN, Steer CJ and Cressman EN:
Molecular mechanisms of hepatocellular carcinoma. Hepatology.
48:2047–2063. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Nelson KM and Weiss GJ: MicroRNAs and
cancer: Past, present, and potential future. Mol Cancer Ther.
7:3655–3660. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ambros V: The functions of animal
microRNAs. Nature. 431:350–355. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Calin GA and Croce CM: MicroRNA signatures
in human cancers. Nat Rev Cancer. 6:857–866. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Esquela-Kerscher A and Slack FJ:
Oncomirs-microRNAs with a role in cancer. Nat Rev Cancer.
6:259–269. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
12
|
Djuranovic S, Nahvi A and Green R:
miRNA-mediated gene silencing by translational repression followed
by mRNA deadenylation and decay. Science. 336:237–240. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell1. 16:281–297. 2004.
View Article : Google Scholar
|
|
14
|
Gu Z, Zhang C and Wang J: Gene regulation
is governed by a core network in hepatocellular carcinoma. BMC Syst
Biol. 6:322012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Gao B, Ning S, Li J, Liu H, Wei W, Wu F,
Tang Y, Feng Y, Li K and Zhang L: Integrated analysis of
differentially expressed mRNAs and miRNAs between hepatocellular
carcinoma and their matched adjacent normal liver tissues. Oncol
Rep. 34:325–333. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zeng L, Yu J, Huang T, Jia H, Dong Q, He
F, Yuan W, Qin L, Li Y and Xie L: Differential combinatorial
regulatory network analysis related to venous metastasis of
hepatocellular carcinoma. BMC Genomics. 13 Suppl 8:S142012.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wang D, Tan J, Xu Y, Tan X, Han M, Tu Y,
Zhu Z, Zen J, Dou C and Cai S: Identification of MicroRNAs and
target genes involvement in hepatocellular carcinoma with
microarray data. Hepatogastroenterology. 62:378–382.
2015.PubMed/NCBI
|
|
18
|
Wang W, Zhao LJ, Tan YX, Ren H and Qi ZT:
Identification of deregulated miRNAs and their targets in hepatitis
B virus-associated hepatocellular carcinoma. World J Gastroenterol.
18:5442–5453. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Han K, Li J, Zhao H, Liang P, Huang X,
Zheng L, Li Y, Yang T and Wang L: Identification of the typical
miRNAs and target genes in hepatocellular carcinoma. Mol Med Rep.
10:229–235. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
He TL, Zheng KL, Li G, Song B and Zhang
YJ: Identification of typical miRNAs and target genes in
hepatocellular carcinoma by DNA microarray technique. Eur Rev Med
Pharmacol Sci. 18:108–116. 2014.PubMed/NCBI
|
|
21
|
Wen LM, Wu WZ and Peng XC: Identifying
significant pathways of hepatitis B virus-related hepatocellular
carcinoma based on crosstalk and network pathways. Genet Mol Res.
15:2016. View Article : Google Scholar :
|
|
22
|
Li J, Shi W, Gao Y, Yang B, Jing X, Shan
S, Wang Y and Du Z: Analysis of microRNA expression profiles in
human hepatitis B virus-related hepatocellular carcinoma. Clin Lab.
59:1009–1015. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Thurnherr T, Mah WC, Lei Z, Jin Y, Rozen
SG and Lee CG: Differentially expressed miRNAs in hepatocellular
carcinoma target genes in the genetic information processing and
metabolism pathways. Sci Rep. 28:200652016. View Article : Google Scholar
|
|
24
|
Katayama Y, Maeda M, Miyaguchi K, Nemoto
S, Yasen M, Tanaka S, Mizushima H, Fukuoka Y, Arii S and Tanaka H:
Identification of pathogenesis-related microRNAs in hepatocellular
carcinoma by expression profiling. Oncol Lett. 4:817–823. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhang Y, Guo X, Xiong L, Yu L, Li Z, Guo
Q, Li Z, Li B and Lin N: Comprehensive analysis of
microRNA-regulated protein interaction network reveals the tumor
suppressive role of microRNA-149 in human hepatocellular carcinoma
via targeting AKT-mTOR pathway. Mol Cancer. 13:2532014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
He D, Liu ZP, Honda M, Kaneko S and Chen
L: Coexpression network analysis in chronic hepatitis B and C
hepatic lesions reveals distinct patterns of disease progression to
hepatocellular carcinoma. J Mol Cell Biol. 4:140–152. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yang Y, Li D, Yang Y and Jiang G: An
integrated analysis of the effects of microRNA and mRNA on
esophageal squamous cell carcinoma. Mol Med Rep. 12:945–952. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Okuda K, Ohtsuki T, Obata H, Tomimatsu M,
Okazaki N, Hasegawa H, Nakajima Y and Ohnishi K: Natural history of
hepatocellular carcinoma and prognosis in relation to treatment.
Study of 850 patients. Cancer. 56:918–928. 1985. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Bruix J and Sherman M: American
Association for the Study of Liver Diseases: Management of
hepatocellular carcinoma: An update. Hepatology. 53:1020–1022.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Leung WK, He M, Chan AW, Law PT and Wong
N: Wnt/β-catenin activates MiR-183/96/182 expression in
hepatocellular carcinoma that promotes cell invasion. Cancer Lett.
362:97–105. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Assal RA, El Tayebi HM, Hosny KA, Esmat G
and Abdelaziz AI: A pleiotropic effect of the single clustered
hepatic metasta miRs miR-96-5p and miR-182-5p on insulin-like
growth factor II, insulin-like growth factor-1 receptor and
insulin-like growth factor-binding protein-3 in hepatocellular
carcinoma. Mol Med Rep. 12:645–650. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Baik SH, Lee J, Lee YS, Jang JY and Kim
CW: ANT2 shRNA downregulates miR-19a and miR-96 through the
PI3K/Akt pathway and suppresses tumor growth in hepatocellular
carcinoma cells. Exp Mol Med. 25:e2222016. View Article : Google Scholar
|
|
34
|
Chen Y, Dong X, Yu D and Wang X: Serum
miR-96 is a promising biomarker for hepatocellular carcinoma in
patients with chronic hepatitis B virus infection. Int J Clin Exp
Med. 8:18462–18468. 2015.PubMed/NCBI
|
|
35
|
Komatsu S, Ichikawa D, Takeshita H,
Morimura R, Hirajima S, Tsujiura M, Kawaguchi T, Miyamae M, Nagata
H, Konishi H, et al: Circulating miR-18a: A sensitive cancer
screening biomarker in human cancer. In Vivo. 28:293–297.
2014.PubMed/NCBI
|
|
36
|
Tan W, Li Y, Lim SG and Tan TM:
miR-106b-25/miR-17-92 clusters: Polycistrons with oncogenic roles
in hepatocellular carcinoma. World J Gastroenterol. 20:5962–5972.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Murakami Y, Tamori A, Itami S, Tanahashi
T, Toyoda H, Tanaka M, Wu W, Brojigin N, Kaneoka Y, Maeda A, et al:
The expression level of miR-18b in hepatocellular carcinoma is
associated with the grade of malignancy and prognosis. BMC Cancer.
13:992013. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Al-Kafaji G, Al-Naieb ZT and Bakhiet M:
Increased oncogenic microRNA-18a expression in the peripheral blood
of patients with prostate cancer: A potential novel non-invasive
biomarker. Oncol Lett. 11:1201–1206. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Huang JY, Zhang K, Chen DQ, Chen J, Feng
B, Song H, Chen Y, Zhu Z, Lu L, De W, et al: MicroRNA-451:
Epithelial-mesenchymal transition inhibitor and prognostic
biomarker of hepatocelluar carcinoma. Oncotarget. 6:18613–18630.
2015.PubMed/NCBI
|
|
40
|
Liu X, Zhang A, Xiang J, Lv Y and Zhang X:
miR-451 acts as a suppressor of angiogenesis in hepatocellular
carcinoma by targeting the IL-6R-STAT3 pathway. Oncol Rep.
36:1385–1392. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Han Y, Kuang Y, Xue X, Guo X, Li P, Wang
X, Guo X, Yuan B, Zhi Q and Zhao H: NLK, A novel target of
miR-199a-3p, functions as a tumor suppressor in colorectal cancer.
Biomed Pharmacother. 68:497–505. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Li SQ, Wang ZH, Mi XG, Liu L and Tan Y:
MiR-199a/b-3p suppresses migration and invasion of breast cancer
cells by downregulating PAK4/MEK/ERK signaling pathway. IUBMB Life.
67:768–777. 2015. View
Article : Google Scholar : PubMed/NCBI
|
|
43
|
Zhou M, Wang S, Hu L, Liu F, Zhang Q and
Zhang D: miR-199a-5p suppresses human bladder cancer cell
metastasis by targeting CCR7. BMC Urol. 16:642016. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Byrnes KA, Phatak P, Mansour D, Xiao L,
Zou T, Rao JN, Turner DJ, Wang JY and Donahue JM: Overexpression of
miR-199a-5p decreases esophageal cancer cell proliferation through
repression of mitogen-activated protein kinase kinase kinase-11
(MAP3K11). Oncotarget. 7:8756–8770. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Song G, Zeng H, Li J, Xiao L, He Y, Tang Y
and Li Y: miR-199a regulates the tumor suppressor mitogen-activated
protein kinase kinase kinase 11 in gastric cancer. Biol Pharm Bull.
33:1822–1827. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Shen Q, Cicinnati VR, Zhang X, Iacob S,
Weber F, Sotiropoulos GC, Radtke A, Lu M, Paul A, Gerken G and
Beckebaum S: Role of microRNA-199a-5p and discoidin domain receptor
1 in human hepatocellular carcinoma invasion. Mol Cancer.
9:2272010. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Hou J, Lin L, Zhou W, Wang Z, Ding G, Dong
Q, Qin L, Wu X, Zheng Y, Yang Y, et al: Identification of miRNomes
in human liver and hepatocellular carcinoma reveals miR-199a/b-3p
as therapeutic target for hepatocellular carcinoma. Cancer Cell.
19:232–243. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Liu L, Lu L, Zheng A, Xie J, Xue Q, Wang
F, Wang X, Zhou H, Tong X, Li Y, et al: MiR-199a-5p and let-7c
cooperatively inhibit migration and invasion by targeting MAP4K3 in
hepatocellular carcinoma. Oncotarget. 8:13666–13677.
2017.PubMed/NCBI
|
|
49
|
Amr KS, Ezzat WM, Elhosary YA, Hegazy AE,
Fahim HH and Kamel RR: The potential role of miRNAs 21 and 199-a in
early diagnosis of hepatocellular carcinoma. Gene. 575:66–70. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Kamel RR, Amr KS, Afify M, Elhosary YA,
Hegazy AE, Fahim HH and Ezzat WM: Relation between microRNAs and
Apoptosis in Hepatocellular Carcinoma. Maced J Med Sci. 4:31–37.
2016. View Article : Google Scholar
|
|
51
|
Kanehisa M and Goto S: KEGG: Kyoto
encyclopedia of genes and genomes. Nucleic Acids Res. 28:27–30.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Lovering RC, Camon EB, Blake JA and Diehl
AD: Access to immunology through the Gene Ontology. Immunology.
125:154–160. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Pinyol R, Nault JC, Quetglas IM,
Zucman-Rossi J and Llovet JM: Molecular profiling of liver tumors:
Classification and clinical translation for decision making. Semin
Liver Dis. 34:363–375. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Shanbhogue AK, Prasad SR, Takahashi N,
Vikram R and Sahani DV: Recent advances in cytogenetics and
molecular biology of adult hepatocellular tumors: Implications for
imaging and management. Radiology. 258:673–693. 2011. View Article : Google Scholar : PubMed/NCBI
|
